Clinical trial
Dose Ranging Study With the Probiotic Combination (VSL#3) in Diarrhea IBS
NCT00179582 · Beth Israel Deaconess Medical Center, Other · Terminated
Key facts
| NCT number | NCT00179582 |
|---|---|
| Title | Dose Ranging Study With the Probiotic Combination (VSL#3) in Diarrhea IBS |
| Official title | A Randomized, Multi-center, Double-blind, Placebo Controlled, Dose Ranging Study With VSL#3 in Diarrhea Predominant IBS Patients |
| Lead sponsor | Beth Israel Deaconess Medical Center, Other |
| Status | Terminated |
| Study type | Interventional |
| Conditions | IBS |
| Intervention type | Drug |
| Interventions | VSL#3 |
| Enrollment | 180 |
| Start date | Jan 1, 2005 |
| Primary completion | Jan 1, 2006 |
| Completion | Jan 1, 2006 |
| First posted | Sep 16, 2005 |
| Last update posted | Feb 27, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: